» Articles » PMID: 36632417

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50-64 Years, 2010-2011 to 2016-2017

Abstract

Background: Understanding the burden of influenza is necessary to optimize recommendations for influenza vaccination. We describe the epidemiology of severe influenza in 50- to 64-year-old residents of metropolitan Toronto and Peel region, Canada, over 7 influenza seasons.

Methods: Prospective population-based surveillance for hospitalization associated with laboratory-confirmed influenza was conducted from September 2010 to August 2017. Conditions increasing risk of influenza complications were as defined by Canada's National Advisory Committee on Immunization. Age-specific prevalence of medical conditions was estimated using Ontario health administrative data. Population rates were estimated using Statistics Canada data.

Results: Over 7 seasons, 1228 hospitalizations occurred in patients aged 50-64 years: 40% due to A(H3N2), 30% A(H1N1), and 22% influenza B. The average annual hospitalization rate was 15.6, 20.9, and 33.2 per 100 000 in patients aged 50-54, 55-59, and 60-64 years, respectively; average annual mortality was 0.9/100 000. Overall, 33% of patients had received current season influenza vaccine; 963 (86%) had ≥1 underlying condition increasing influenza complication risk. The most common underlying medical conditions were chronic lung disease (38%) and diabetes mellitus (31%); 25% of patients were immunocompromised. The average annual hospitalization rate was 6.1/100 000 in those without and 41/100 000 in those with any underlying condition, and highest in those with renal disease or immunocompromise (138 and 281 per 100 000, respectively). The case fatality rate in hospitalized patients was 4.4%; median length of stay was 4 days (interquartile range, 2-8 days).

Conclusions: The burden of severe influenza in 50- to 64-year-olds remains significant despite our universal publicly funded vaccination program. These data may assist in improving estimates of the cost-effectiveness of new strategies to reduce this burden.

Citing Articles

Influenza and Aging: Clinical Manifestations, Complications, and Treatment Approaches in Older Adults.

Rosero C, Gravenstein S, Saade E Drugs Aging. 2025; 42(1):39-55.

PMID: 39775605 DOI: 10.1007/s40266-024-01169-y.


Age, comorbidity burden and late presentation are significant predictors of hospitalization length and acute respiratory failure in patients with influenza.

Miron V, Sandulescu O, Streinu-Cercel A, Florea D, Paraschiv S, Banica L Sci Rep. 2024; 14(1):15563.

PMID: 38971866 PMC: 11227496. DOI: 10.1038/s41598-024-66550-8.


Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015-2020 Influenza Seasons.

McGovern I, Cappell K, Bogdanov A, Haag M Clin Infect Dis. 2024; 79(3):778-786.

PMID: 38567481 PMC: 11426264. DOI: 10.1093/cid/ciae180.


Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021-2023.

Fall A, Han L, Yunker M, Gong Y, Li T, Norton J Open Forum Infect Dis. 2023; 10(12):ofad577.

PMID: 38088981 PMC: 10715682. DOI: 10.1093/ofid/ofad577.


The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence.

Marchi S, Fallani E, Salvatore M, Montomoli E, Trombetta C Hum Vaccin Immunother. 2023; 19(2):2257048.

PMID: 37778401 PMC: 10760501. DOI: 10.1080/21645515.2023.2257048.

References
1.
Wallemacq S, Danwang C, Scohy A, Belkhir L, De Greef J, Kabamba B . A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium. J Infect Chemother. 2022; 28(11):1489-1493. PMC: 9356567. DOI: 10.1016/j.jiac.2022.07.012. View

2.
Kwong J, Schwartz K, Campitelli M, Chung H, Crowcroft N, Karnauchow T . Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018; 378(4):345-353. DOI: 10.1056/NEJMoa1702090. View

3.
Sherry B, Jefferds M, Grummer-Strawn L . Accuracy of adolescent self-report of height and weight in assessing overweight status: a literature review. Arch Pediatr Adolesc Med. 2007; 161(12):1154-61. DOI: 10.1001/archpedi.161.12.1154. View

4.
Arriola C, Garg S, Anderson E, Ryan P, George A, Zansky S . Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza. Clin Infect Dis. 2017; 65(8):1289-1297. PMC: 5718038. DOI: 10.1093/cid/cix468. View

5.
Skowronski D, Leir S, Sabaiduc S, Chambers C, Zou M, Rose C . Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada. J Infect Dis. 2020; 225(8):1387-1398. PMC: 9016427. DOI: 10.1093/infdis/jiaa138. View